MOBILion Systems Establishes Proteomics Advisory Board to Enhance Innovative Sample Analysis Technology

MOBILion Systems, Inc. has announced the formation of a Proteomics Advisory Board, consisting of seven experts in the field of proteomics. The board will guide the company in advancing complex sample analysis technology, with the goal of revolutionizing mass spectrometry to enable precise analysis, targeting low-abundance signals, and identifying complex biomolecules. Daniel DeBord, Ph.D., CTO of MOBILion Systems, expressed his excitement about working with these visionary leaders who have made significant contributions to the proteomics landscape. The company’s PAMAF operating mode is said to set a new standard for speed and sensitivity in complex sample analysis. The board’s expertise will help ensure that MOBILion Systems develops products that effectively leverage this technology to address the primary challenges faced by researchers in the field. The company’s mission is to redefine what is possible in proteomics research and innovation. For more information, please contact Healthcare Edge Editor at Editor@Executives-edge.com.

Source
Photo credit finance.yahoo.com